Solé Llop Mª Esther, Cano Del Pozo Mabel, García Montero José-Ignacio, Carrera-Lasfuentes Patricia, Lanas Ángel
Laboratorio de Bioquímica, Hospital de Alcañiz, Alcañiz (Teruel), España.
Dirección General de Asistencia Sanitaria, Departamento de Sanidad, Gobierno de Aragón, Zaragoza, España.
Gac Sanit. 2018 Nov-Dec;32(6):559-562. doi: 10.1016/j.gaceta.2017.05.014. Epub 2017 Aug 4.
To describe preliminary findings from the colorectal cancer screening programme in Aragon (Spain) to evaluate its implementation.
We have collected data from the first year of the program (2014) based on faecal occult blood immunochemical (FOBTi) test in patients 60-69 years old. We report "indicators" defined by the "Red Nacional de Cribado".
Invited population after exclusions: 12,518. Program participation rate: 45.28% (95%CI: 44.41-46.15). Inadequate tests: 0.21% (95%CI: 0.12-0.37); positive FOBTi test 10.75% (95%CI: 9.97-11.58) and colonoscopy acceptance 95.07% (95%CI: 93.04-96.52). Colonoscopy was appropriate and complete in 97.58% (95%CI: 95.98-98.55) of cases. The high- and low-risk adenoma detection rates were 14.7‰ (95%CI: 11.9-18.2) and 5.55‰ (95%CI: 3.9-7.8) respectively. The positive predictive value for any adenoma was 58.55% (95%CI: 54.49-62.49) and for invasive cancer was 5.36% (95%CI: 3.8-7.51).
The indicator analysis of the ongoing programme suggests the programme is being implemented correctly in our community.
描述西班牙阿拉贡地区结直肠癌筛查项目的初步结果，以评估其实施情况。
我们收集了该项目第一年（2014年）基于60 - 69岁患者粪便免疫化学潜血试验（FOBTi）的数据。我们报告了由“国家筛查网络”定义的“指标”。
排除后受邀人群为12,518人。项目参与率为45.28%（95%置信区间：44.41 - 46.15）。不合格检测率为0.21%（95%置信区间：0.12 - 0.37）；FOBTi检测阳性率为10.75%（95%置信区间：9.97 - 11.58），结肠镜检查接受率为95.07%（95%置信区间：93.04 - 96.52）。结肠镜检查在97.58%（95%置信区间：95.98 - 98.55）的病例中是合适且完整的。高危和低危腺瘤检出率分别为14.7‰（95%置信区间：11.9 - 18.2）和5.55‰（95%置信区间：3.9 - 7.8）。任何腺瘤的阳性预测值为58.55%（95%置信区间：54.49 - 62.49），浸润性癌的阳性预测值为5.36%（95%置信区间：3.8 - 7.51）。
对正在进行的项目的指标分析表明，该项目在我们社区得到了正确实施。
